ENCePP web header
ENCePP web header
  • Ruthsarian
  • Home
  • Sitemap
  • Q & A
  • Notice Board
    • PhEpi & PhV activities
    • Research Funding
    • Conferences & meetings
    • Recruitment
  • Links
  • Contact Us

Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised Impact of EU label changes for hydroxyzine products: post-referral prescribing trends Professor Thomas MacDonald 06/01/2021
Finalised Impact of EU label changes for systemic diclofenac products: post-referral prescribing trends Professor Thomas MacDonald 16/02/2020
Ongoing Development of a Multivariable Model to Predict the Risk of Dose Delays following Chemotherapy Ms Chambers Pinkie 22/05/2020

  • News
  • About Us
  • ENCePP Documents
  • Training in PhEpi and PV

  • Code of Conduct
  • Standards & Guidances
  • ENCePP Study Seal
  • Public Consultation
  • Glossary of terms

  • Resources Database

  • Partners forum

  • EU PAS Register

  • About EU PAS Register
© 1995-2023 European Medicines Agency | Contact Us | Privacy Policy | Admin Login | Disclaimer

For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI


combined emea eu logo European Medicines Agency Europa Website
Version: 4.5.4.0